ArrowMark Colorado Holdings LLC 13D and 13G filings for TCR2 Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-02-16 1:29 pm Sale | 2020-12-31 | 13G | TCR2 Therapeutics Inc. TCRR | ArrowMark Colorado Holdings LLC | 1,167,220 3.500% | -102,546 (-8.08%) | Filing |